Q-omics provides the consensus-scored SLC7A5P2 profile across patient tissues and cancer cell-line models. Additionally, SLC7A5P2 mutation status shows 2 significant gene co-expression associations, with the highest sampling consensus in BLCA.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SLC7A5P2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SLC7A5P2 in patient tissues and cancer cell lines. In patient samples, SLC7A5P2 shows the broadest associations at the RNA and protein expression levels, with BLCA recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼Mutation
RNA	2	BLCA (2)	view →
▼RNA
Drug	1	PEMB_ALL (1)	view →